Patents Assigned to VENTHERA, INC.
  • Topical phosphoinositide 3-kinase inhibitors
    Patent number: 12522614
    Abstract: The present invention provides compounds and topical formulations including the compounds for the treatment of vascular malformations, wherein the compounds are according to formula (I): wherein subscript m, L1, R1, and L1-R1 are as described herein.
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: January 13, 2026
    Assignee: Venthera, Inc.
    Inventors: Ahmed F. Abdel-Magid, Agis Kydonieus, Thomas Rossi, Hock S. Tan
  • Topical phosphoinositide 3-kinase inhibitors
    Patent number: 11661429
    Abstract: The present invention provides compounds and topical formulations including the compounds for the treatment of vascular malformations, wherein the compounds are according to formula (I): wherein subscript m, L1, R1, and L1-R1 are as described herein.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: May 30, 2023
    Assignee: VENTHERA, INC.
    Inventors: Ahmed F. Abdel-Magid, Agis Kydonieus, Thomas Rossi, Hock S. Tan